list of participants - IARC Monographs on the Evaluation of

LIST OF PARTICIPANTS
Members1
Bruce C. Baguley
Auckland Cancer Society Research Centre
University of Auckland
Auckland
New Zealand
Frederick A. Beland
National Center for Toxicological Research
Food and Drug Administration
Jefferson, AR
USA
Joseph M. Betz (Subgroup chair, Exposure
Data)
Office of Dietary Supplements
National Institutes of Health
Rockville, MD
USA
Robert J. Biggar
Queensland University of Technology
Brisbane
Australia
Esperanza J. Carcache de Blanco
College of Pharmacy
Ohio State University
Columbus, OH
USA
Michael L. Cunningham [retired]
National Institute of Environmental Health
Sciences
Chapel Hill, NC
USA
Working Group Members and Invited Specialists serve in their individual capacities as scientists and not as
representatives of their government or any organization with which they are affiliated. Affiliations are provided for identification purposes only. Invited Specialists do not serve as Meeting Chair or Subgroup Chair, draft text that pertains to
the description or interpretation of cancer data, or participate in the evaluations.
Each participant was asked to disclose pertinent research, employment, and financial interests. Current financial
interests and research and employment interests during the past 4 years or anticipated in the future are identified here.
Minor pertinent interests are not listed and include stock valued at no more than US $1000 overall, grants that provide
no more than 5% of the research budget of the expert’s organization and that do not support the expert’s research or
position, and consulting or speaking on matters not before a court or government agency that does not exceed 2% of
total professional time or compensation. All grants that support the expert’s research or position and all consulting
or speaking on behalf of an interested party on matters before a court or government agency are listed as significant
pertinent interests.
1
3
IARC MONOGRAPHS – 108
June K. Dunnick
Toxicology Branch
National Institute of Environmental Health
Sciences
Research Triangle Park, NC
USA
Dirk W. Lachenmeier
Ministry of Rural Region and Consumer
Protection Baden-Württemberg
Stuttgart
Germany
Ruth M. Lunn
Lei Guo
National Center for Toxicological Research
Food and Drug Administration
Jefferson, AR
USA
Charles William Jameson (Subgroup Chair,
Cancer in Experimental Animals)
CWJ Consulting, LLC
Cape Coral, FL
USA
Margaret Karagas (Subgroup Chair, Cancer in
Humans)
Section of Biostatistics and Epidemiology
Dartmouth Medical School
Lebanon, NH
USA
National Toxicology Program
National Institute of Environmental Health
Sciences
Research Triangle Park, NC
USA
M. Matilde Marques (Subgroup Chair,
Mechanistic and Other Relevant Data)
Department of Chemical and Biological
Engineering
Technical University of Lisbon
Lisbon
Portugal
David L. McCormick
IIT Research Institute
Chicago, IL
USA
Sonal Singh
Trudy L. Knight
Institute of Occupational Environmental
Medicine
University of Birmingham
Birmingham
United Kingdom
4
Department of Epidemiology
Johns Hopkins School of Medicine and Public
Health
Baltimore, MD
USA
Participants
Saranjit Singh [unable to attend]
Department of Pharmaceutical Analysis
National Institute of Pharmaceutical
Education and Research
Punjab
India
Bernard W. Stewart (Overall Chair)
Cancer Control Program
South Eastern Sydney Public Health Unit
Randwick
Australia
Chin-Hsiao Tseng 2
College of Medicine
Taiwan University
Taipei
Taiwan, China
Hiroyuki Tsuda
Nanotoxicology Project
Nagoya City University
Nagoya
Japan
Kristine L. Witt [unable to attend]
National Toxicology Program
National Institute of Environmental Health
Sciences
Research Triangle Park, NC
USA
Shufeng Zhou
College of Pharmacy
University of South Florida
Tampa, FL
USA
Invited specialist
Randall S. Stafford 3
Program on Prevention Outcomes and
Practices
Stanford Prevention Research Center
Stanford, CA
USA
Observers
David Alexander 4 [unable to attend]
Williams Kherkher Hart Boundas, LLP
League City, Texas
USA
Andrea Bertocco 5
Global Products Science & Safety EMEA
Herbalife Europe Limited
Uxbridge
England
Chin-Hsiao Tseng received non-significant honoraria for serving on advisory boards and presentations from pharmaceutical companies, including Bristol-Myers-Squibb Company, Eli Lilly and Company, and Takeda Pharmaceutical
Company Limited.
3
Randall S. Stafford provided expert testimony (ceased in 2011) for Mylan Pharmaceuticals, Morgantown, WV, manufacturer of generic drugs, including hydrochlorothiazide containing drugs.
4
David Alexander represents clients who claim they have been injured by the drug pioglitazone. He is employed and
sponsored by Williams Kherkher Hart Boundas, LLP, Houston Texas, USA.
5
Andrea Bertocco is employed by Herbalife, where he served as regulatory Manager for Herbalife products containing
Aloe vera, Goldenseal and Ginkgo biloba. He is sponsored by Herbalife Europe Limited, England.
2
5
IARC MONOGRAPHS – 108
Paul Dolin 6
Takeda Global Research & Development
Centre (Europe) Ltd
London
England
Olaf Kelber 7
World Self-Medication Industry
Steigerwald Arzneimittelwerk GmbH
Darmstadt
Germany
Egon Koch 8
World Self-Medication Industry
Dr. Willmar Schwabe GmbH & Co. KG
Karlsruhe
Germany
Yann Grosse (Responsible Officer, Rapporteur
Cancer in Experimental Animals)
Neela Guha (Rapporteur Cancer in Humans)
Kate Z. Guyton
Béatrice Lauby-Secretan (Rapporteur
Exposure Data)
Ho-Sun Lee
Dana Loomis (Rapporteur Cancer in Humans)
Heidi Mattock (Scientific Editor)
Douglas Puricelli Perin
Mónica S. Sierra
Kurt Straif (Head of Programme)
Jiri Zavadil
Administrative Assistance
Sandrine Egraz
Brigitte Kajo
Michel Javin
Annick Leroux
Helene Lorenzen-Augros
IARC Secretariat
Melina Arnold
Robert Baan (Senior Visiting Scientist)
Helen Bailey
Lamia Benbrahim-Tallaa (Rapporteur
Mechanistic and Other Relevant Data)
Véronique Bouvard (Rapporteur Exposure
Data)
Fatiha El Ghissassi (Rapporteur Mechanistic
and Other Relevant Data)
Akram Ghantous
Production Team
Elisabeth Elbers
Solène Quennehen
Dorothy Russell
Paul Dolin is employed and sponsored by Takeda Pharmaceutical Company Limited, Europe, manufacturing pioglitazone-containing and other pharmaceutical drugs. He holds stock of pharmaceutical companies marketing drugs that
are reviewed at this meeting.
7
Olaf Kelber is employed by Steigerwald Arzneimittelwerk GmbH, Darmstadt, Germany, manufacturing herbal medicines. He is sponsored by the World-Self-Medication Industry (WSMI), France.
8
Egon Koch is employed by Dr. Wilmar Schwabe GmbH & Co KG, Karlsruhe, Germany. He provides expert testimony
with respect to the commercialization of Ginkgo biloba extracts. He is sponsored by the World-Self-Medication Industry (WSMI), France.
6
6